Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors – MedCity News
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques,…
Michelle Carnahan has spent the better part of the last three decades working in healthcare at companies like Thirty Madison…
Eli Lilly (NYSE:LLY) just pre-announced a $1.57 billion pre-tax charge related to acquired in-process R&D, which is expected to weigh…